Literature DB >> 2447925

Mortality in heart failure: clinical variables of prognostic value.

J G Cleland1, H J Dargie, I Ford.   

Abstract

One hundred and fifty two patients with chronic heart failure caused primarily by left ventricular dysfunction were followed prospectively in an open study for a mean period of 21 months. The effects of several clinical variables on subsequent outcome were examined, including the effects of treatment, which was determined by the clinician caring for the patient and was not randomly allocated. In order of importance, frequent ventricular extrasystoles, non-treatment with amiodarone, low mean arterial pressure, and a diagnosis of coronary artery disease were associated with a poor prognosis, with each of these variables providing extra predictive information independently of the others. Initial serum potassium concentration and treadmill exercise time also carried further weak but independent prognostic information. Neither treatment with angiotensin converting enzyme inhibitors nor digoxin appeared to affect outcome. Left ventricular function (as reflected by M mode echocardiography) and the dose of diuretic also failed to predict outcome. There did, however, appear to be a reduction in the frequency of sudden death when angiotension converting enzyme inhibitors were given. Further studies are required to confirm the adverse prognostic significance of ventricular arrhythmias in patients with heart failure and the possible benefit associated with amiodarone treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447925      PMCID: PMC1277308          DOI: 10.1136/hrt.58.6.572

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  46 in total

1.  Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.

Authors:  M Packer; N Medina; M Yushak; J Meller
Journal:  Circulation       Date:  1983-10       Impact factor: 29.690

2.  Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia.

Authors:  C P Reddy; L S Gettes
Journal:  Am J Cardiol       Date:  1979-10       Impact factor: 2.778

3.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

4.  Determinants of clinical response and survival in patients with congestive heart failure treated with captopril.

Authors:  M A Creager; D P Faxon; J L Halperin; C D Melidossian; C H McCabe; E C Schick; T J Ryan
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749

5.  Correlative studies of serum digitalis levels and the arrhythmias of digitalis intoxication.

Authors:  W Shapiro
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

6.  Ventricular arrhythmias in idiopathic dilated cardiomyopathy.

Authors:  K von Olshausen; A Schäfer; H C Mehmel; F Schwarz; J Senges; W Kübler
Journal:  Br Heart J       Date:  1984-02

7.  Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure.

Authors:  D R Glover; W A Littler
Journal:  Br Heart J       Date:  1987-02

8.  Factors influencing the one-year mortality of dilated cardiomyopathy.

Authors:  D V Unverferth; R D Magorien; M L Moeschberger; P B Baker; J K Fetters; C V Leier
Journal:  Am J Cardiol       Date:  1984-07-01       Impact factor: 2.778

9.  Correlates and prognostic implication of exercise capacity in chronic congestive heart failure.

Authors:  J Szlachcic; B M Massie; B L Kramer; N Topic; J Tubau
Journal:  Am J Cardiol       Date:  1985-04-01       Impact factor: 2.778

10.  Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.

Authors:  J G Cleland; H J Dargie; S G Ball; G Gillen; G P Hodsman; J J Morton; B W East; I Robertson; I Ford; J I Robertson
Journal:  Br Heart J       Date:  1985-09
View more
  35 in total

1.  Chronic heart failure.

Authors:  M Cripwell; D Patterson
Journal:  Occas Pap R Coll Gen Pract       Date:  1992-12

Review 2.  Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 3.  Angiotensin converting enzyme inhibitors for hypertension and heart failure?

Authors:  J G Cleland
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

4.  Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol.

Authors:  E Vigholt-Sørensen; O Faergeman
Journal:  Br Heart J       Date:  1990-09

Review 5.  Is aspirin safe for patients with heart failure?

Authors:  J G Cleland; C J Bulpitt; R H Falk; I N Findlay; C M Oakley; G Murray; P A Poole-Wilson; C R Prentice; G C Sutton
Journal:  Br Heart J       Date:  1995-09

6.  Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study.

Authors:  M G Modena; N Muia; F A Sgura; R Molinari; A Castella; R Rossi
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

Review 7.  ACE inhibitors and arrhythmias.

Authors:  R W Campbell
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

8.  Role of orthotopic heart transplantation in the management of patients with recurrent ventricular tachyarrhythmias following myocardial infarction.

Authors:  J P Bourke; A Loaiza; G Parry; C Hilton; S Furniss; J Dark; J Forty
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

Review 9.  Modern treatment of heart failure.

Authors:  A D Timmis
Journal:  BMJ       Date:  1988-07-09

Review 10.  Treatment of congestive heart failure--state of the art and future trends.

Authors:  W W Parmley
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.